Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine PK in Pediatric Spinal Fusion
NCT05755334Phase 4Unknown
- Sponsor
- McGill University Health Centre
- Start
- Jun 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by McGill University Health Centre. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05755334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05755334.